India’s bioeconomy, which includes biotech, pharma and agriculture, officially valued at 165 billion dollars in 2024, was expected to reach $300 billion by 2030, Prof. Sudhir Kumar Sopory, President ...

The government had launched the Biopharma Mission at the national level, while other programs included Bio AI Hubs, Bio Agriculture and Bioenergy, Prof. Sopory said while addressing the inaugural ...

India and Israel launch a joint venture to commercialize sustainable agricultural technologies, enhancing global crop ...

ATGC Biotech, a leading Indian innovator in pheromone and semiochemical-based crop protection, on Tuesday announced the ...

Hyderabad-based pheromone and semiochemical-based crop protection firm ATGC Biotech and Israel-based Luxembourg Industries ...

BioLizard has supported the development of novel biomarker programs, contributed to AI-driven drug discovery efforts, and ...

ATGC Biotech and Luxembourg Industries form Semiophore Ltd, a joint venture for crop protection with USD 10M investment.

Brazilian sugarcane biotechnologist Dr William Lee Burnquist stressed the need for biotech-driven sustainable sugarcane ...

Semiophore, a new Indo-Israeli venture, will scale India’s pheromone-based crop protection tech to cut pesticide use and ...

Gain insights into the U.S. market, valued at $5.9 Billion in 2024, and China, forecasted to grow at an impressive 14.4% CAGR to reach $7.8 Billion by 2030. Discover growth trends in other key regions ...

Resolution 57-NQ/TW is not merely a policy document; it is a rallying call and a compass guiding a new, strong, and ...

The JV plans to commercialise 18 semiochemical and pheromone technologies developed by ATGC Biotech in multiple international ...